Peter Heisig
Impact in
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria
- Endocrinology top 1%
Papers in
-
- Antibiotic Resistance in Bacteria 34
-
- Cancer therapeutics and mechanisms 16
- Co-authors
- B. Wiedemann (12 shared papers)Jens Vorbeck (11 shared papers)Kai Mertins (12 shared papers)Anke Heisig (9 shared papers)Arne C. Rodloff (2 shared papers)Florinda Matos (1 shared paper)Wolfgang Schöll (2 shared papers)Johan W. Mouton (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (16 papers)Journal of Antimicrobial Chemotherapy (7 papers)Journal of Knowledge Management (6 papers)Microbial Drug Resistance (4 papers)Bioorganic Chemistry (2 papers)
- Partner nations
- GermanyUnited KingdomNetherlands
In The Last Decade
Peter Heisig
113 papers receiving 4.2k citations
Peter Heisig's Hit Papers
Peers
Comparison fields: 5 of 183
- Molecular Medicine 1.5k
- Endocrinology 433
- Communication 600
- Applied Microbiology and Biotechnology 98
- Strategy and Management 765
Countries citing papers authored by Peter Heisig
This map shows the geographic impact of Peter Heisig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Heisig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Heisig more than expected).
Fields of papers citing papers by Peter Heisig
This network shows the impact of papers produced by Peter Heisig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Heisig. The network helps show where Peter Heisig may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Heisig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | EUCAST expert rules in antimicrobial susceptibility testing Hit paper breakdown → | 2011 | 530 |
| 2 | 2009 | 420 | |
| 3 | 1996 | 245 | |
| 4 | 1999 | 176 | |
| 5 | 2017 | 144 | |
| 6 | 2016 | 141 | |
| 7 | 2000 | 140 | |
| 8 | 2004 | 130 | |
| 9 | Knowledge Management: Best Practices in Europe | 2000 | 120 |
| 10 | 1994 | 111 | |
| 11 | 1993 | 108 | |
| 12 | 2011 | 102 | |
| 13 | 1993 | 96 | |
| 14 | 2006 | 85 | |
| 15 | 1999 | 79 | |
| 16 | 2010 | 76 | |
| 17 | 1994 | 72 | |
| 18 | 2001 | 70 | |
| 19 | 2012 | 66 | |
| 20 | 2010 | 54 |
About Peter Heisig
Peter Heisig is a scholar working on Molecular Medicine, Molecular Biology, Pharmacology, Strategy and Management and Management Information Systems, having authored 121 papers that have together received 4.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (34 papers), Antibiotics Pharmacokinetics and Efficacy (20 papers), Cancer therapeutics and mechanisms (16 papers), Knowledge Management and Sharing (12 papers), Business Process Modeling and Analysis (11 papers), Innovation and Knowledge Management (9 papers), Antimicrobial Resistance in Staphylococcus (9 papers) and Bacterial Genetics and Biotechnology (6 papers). The work is most often cited by research in Molecular Medicine (1.5k citations), Endocrinology (433 citations), Communication (600 citations), Applied Microbiology and Biotechnology (98 citations) and Strategy and Management (765 citations). Peter Heisig has collaborated with scholars based in Germany, United Kingdom and Netherlands. Frequent co-authors include B. Wiedemann, Jens Vorbeck, Kai Mertins, Anke Heisig, Arne C. Rodloff, Florinda Matos, Wolfgang Schöll, Johan W. Mouton, C J Soussy and Alasdair MacGowan. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Journal of Knowledge Management, Microbial Drug Resistance and Bioorganic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.